Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · IEX Real-Time Price · USD
27.55
-0.69 (-2.44%)
At close: Jul 2, 2024, 4:00 PM
26.97
-0.58 (-2.11%)
After-hours: Jul 2, 2024, 6:28 PM EDT
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $1.04 billion as of July 2, 2024. Its market cap has increased by 112.77% in one year.
Market Cap
1.04B
Enterprise Value
772.29M
1-Year Change
112.77%
Ranking
Category
Stock Price
$27.55
Market Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $1.04B, an increase of 237.79%. That is a compound annual growth rate of 38.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 1.07B | 59.16% |
| Dec 29, 2023 | 670.40M | 71.46% |
| Dec 30, 2022 | 391.00M | -15.95% |
| Dec 31, 2021 | 465.20M | -44.61% |
| Dec 31, 2020 | 839.80M | 172.53% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4D Molecular Therapeutics | 1.11B |
| Prothena Corporation | 1.10B |
| AtriCure | 1.08B |
| Enliven Therapeutics | 1.08B |
| Silk Road Medical | 1.07B |
| Collegium Pharmaceutical | 1.06B |
| Artivion | 1.06B |
| Ironwood Pharmaceuticals | 1.04B |